XML 57 R49.htm IDEA: XBRL DOCUMENT
v3.22.1

Acquisition Contract Liabilities (Details Narrative) $ in Millions | Mar. 25, 2019 USD ($)
--- | ---
Monte Carlo Simulation Model [Member] | Measurement Input, Discount Rate [Member] |
Restructuring Cost and Reserve [Line Items] |
Derivative liability measuremnet input | 0.060
Cutanea Life Sciences Inc [Member] |
Restructuring Cost and Reserve [Line Items] |
Equity interest in acquiree, percentage | 100.00%
Biofrontera AG [Member] |
Restructuring Cost and Reserve [Line Items] |
Equity interest in acquiree, percentage | 29.90%
Maruho Co Ltd [Member] |
Restructuring Cost and Reserve [Line Items] |
Sale of equity estimated profits contingent consideration | $ 6.5
Start-up cost financing interest rate | 6.00%
Start-up cost financing term | 57 months
Start-up cost financing maturity date | Dec. 31, 2023
Maruho Co Ltd [Member] | Share Purchase Agreement [Member] |
Restructuring Cost and Reserve [Line Items] |
Start-up cost financing | $ 7.3
Xepi [Member] |
Restructuring Cost and Reserve [Line Items] |
Start-up cost financing | 7.3
Non-interest bearing start-up cost financing | $ 1.7

X
- Definition Non interest bearing startup financing cost. + References No definition available. + Details
Name: | BFRI_NoninterestBearingStartupFinancingCost
Namespace Prefix: | BFRI_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Sale of equity estimated profits of contingent consideration. + References No definition available. + Details
Name: | BFRI_SaleOfEquityEstimatedProfitsOfContingentConsideration
Namespace Prefix: | BFRI_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Start up financing costs. + References No definition available. + Details
Name: | BFRI_StartUpFinancingCosts
Namespace Prefix: | BFRI_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Startup cost financing interest rate. + References No definition available. + Details
Name: | BFRI_StartupCostFinancingInterestRate
Namespace Prefix: | BFRI_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Startup cost financing maturity date. + References No definition available. + Details
Name: | BFRI_StartupCostFinancingMaturityDate
Namespace Prefix: | BFRI_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | duration

X
- Definition Startup cost financing term. + References No definition available. + Details
Name: | BFRI_StartupCostFinancingTerm
Namespace Prefix: | BFRI_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of equity in the acquiree held by the acquirer immediately before the acquisition date in a business combination. + References No definition available. + Details
Name: | us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Value of input used to measure derivative liability. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (bbb)(2) -URI https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258 + Details
Name: | us-gaap_DerivativeLiabilityMeasurementInput
Namespace Prefix: | us-gaap_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_RestructuringCostAndReserveLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_ValuationTechniqueAxis=BFRI_MonteCarloSimulationModelMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=BFRI_CutaneaLifeSciencesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=BFRI_BiofronteraAGMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=BFRI_MaruhoCoLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=BFRI_SharePurchaseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=BFRI_XepiMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |